ViiV's Waterhouse exits to take the CEO job at CSL
CSL has named Deborah Waterhouse as its new chief executive, on the same day her departure from the same role at ViiV was announced.
Newsletters and Deep Dive digital magazine
CSL has named Deborah Waterhouse as its new chief executive, on the same day her departure from the same role at ViiV was announced.
Novo continues to build the case for its new weight-loss candidate CagriSema, pointing to new data that show strong efficacy in women.
Trials of Lilly's Omvoh, Gilead's emvistegrast, Takeda's Entyvio, AbbVie's ABBV-466, and Sanofi/Teva's duvakitug are highlights of UEGW.
AstraZeneca has launched a project with tech giant Oracle that will use AI and real-world data to improve clinical research and patient care.
A year after signing a first deal with Hansoh worth up to $1.45 billion, Roche has returned for another that could be more than 10 times larger.
Editor's Picks
Newsletters and Deep Dive
digital magazine